Javascript is required to run this page

HB732

Public schools; opioid antagonist administration, etc.

Status:
Enacted

Chief Patron:
Briana Sewell (D)

Session:
2024 Regular Session

Summary

As Passed Both Chambers. Public schools; opioid antagonist procurement, possession, and administration; school board employee training and certification; opioid overdose prevention and reversal instruction; guidelines and requirements.

Requires each local school board to develop, in accordance with the guidelines developed by the Department of Health in collaboration with the Department of Education, plans, policies, and procedures for (i) providing at each public secondary school that includes grades nine through 12 a program of instruction on opioid overdose prevention and reversal and for encouraging each student to complete such program of instruction prior to graduation; (ii) the procurement, placement, and maintenance in each public elementary and secondary school of a supply of opioid antagonists in an amount equivalent to at least two unexpired doses for the purposes of opioid overdose reversal; and (iii) the possession and administration of an opioid antagonist by any employee of the school board who is authorized by a prescriber and trained in the administration of an opioid antagonist, including policies (a) requiring each public elementary and secondary school to ensure that at least one employee is authorized by a prescriber and trained and certified in the administration of an opioid antagonist, (b) for partnering with a program administered or approved by the Department of Health to provide such training and certification, and (c) for maintaining records of each such trained and certified employee.

The bill provides for the disciplinary, civil, and criminal immunity of any employee of a public school, school board, or local health department, regardless of whether such employee was trained or certified in opioid antagonist administration, for any act or omission made in connection with the good faith administration of an opioid antagonist for the purposes of opioid overdose reversal during regular school hours, on school premises, or during a school-sponsored activity, unless such act or omission was the result of gross neglect or willful misconduct. The bill requires each school board to adopt and each public elementary and secondary school to implement policies and procedures in accordance with the provisions of the bill and, in doing so, to utilize to the fullest extent possible programs offered by the Department of Health for the provision of opioid antagonist administration training and certification and opioid antagonist procurement.

In addition, the bill modifies the school board employees who are authorized to administer opioid antagonists to include any school board employee who has completed training and is certified in the administration of an opioid antagonist by a program administered or authorized by the Department of Health.

Finally, the bill directs the Department of Health and the Department of Education to collaborate to develop guidelines and policies for the implementation of the provisions of the bill and requires each school board to implement the provisions of the bill by the beginning of the 2025–2026 school year. This bill is identical to SB 726. (Less)
  • Bill History

  • 01/09/2024 - House: Prefiled and ordered printed; offered 01/10/24 24104968D
  • 01/09/2024 - House: Referred to Committee on Education
  • 01/19/2024 - House: Assigned Education sub: K-12 Subcommittee
  • 01/23/2024 - House: House subcommittee amendments and substitutes offered
  • 01/23/2024 - House: Subcommittee recommends reporting with substitute (8-Y 0-N)
  • 01/23/2024 - House: Subcommittee recommends referring to Committee on Appropriations
  • 01/24/2024 - House: Reported from Education with substitute (21-Y 0-N)
  • 01/24/2024 - House: Committee substitute printed 24105987D-H1
  • 01/24/2024 - House: Referred to Committee on Appropriations
  • 01/25/2024 - House: Assigned App. sub: Elementary & Secondary Education
  • 01/30/2024 - House: Impact statement from DPB (HB732H1)
  • 02/05/2024 - House: House subcommittee amendments and substitutes offered
  • 02/05/2024 - House: Subcommittee recommends reporting with amendments (8-Y 0-N)
  • 02/07/2024 - House: Reported from Appropriations with amendment(s) (22-Y 0-N)
  • 02/08/2024 - House: House committee, floor amendments and substitutes offered
  • 02/09/2024 - House: Read first time
  • 02/12/2024 - House: Read second time
  • 02/12/2024 - House: Committee on Education substitute agreed to 24105987D-H1
  • 02/12/2024 - House: Committee on Appropriations amendment agreed to
  • 02/12/2024 - House: Engrossed by House - committee substitute with amendment HB732EH1
  • 02/12/2024 - House: Printed as engrossed 24105987D-EH1
  • 02/13/2024 - House: Read third time and passed House BLOCK VOTE (99-Y 0-N)
  • 02/13/2024 - House: VOTE: Block Vote Passage (99-Y 0-N)
  • 02/14/2024 - Senate: Constitutional reading dispensed
  • 02/14/2024 - Senate: Referred to Committee on Education and Health
  • 02/20/2024 - House: Impact statement from DPB (HB732EH1)
  • 02/21/2024 - Senate: Assigned Education and Health Sub: Public Education
  • 02/22/2024 - Senate: Senate subcommittee amendments and substitutes offered
  • 02/29/2024 - Senate: Reported from Education and Health with substitute (15-Y 0-N)
  • 02/29/2024 - Senate: Committee substitute printed 24108126D-S1
  • 03/01/2024 - House: Impact statement from DPB (HB732S1)
  • 03/01/2024 - Senate: Constitutional reading dispensed (40-Y 0-N)
  • 03/04/2024 - Senate: Read third time
  • 03/04/2024 - Senate: Reading of substitute waived
  • 03/04/2024 - Senate: Committee substitute agreed to 24108126D-S1
  • 03/04/2024 - Senate: Engrossed by Senate - committee substitute HB732S1
  • 03/04/2024 - Senate: Passed Senate with substitute (39-Y 0-N)
  • 03/05/2024 - House: Passed by for the day
  • 03/06/2024 - House: Senate substitute agreed to by House 24108126D-S1 (97-Y 1-N)
  • 03/06/2024 - House: VOTE: Adoption (97-Y 1-N)
  • 03/25/2024 - House: Enrolled
  • 03/25/2024 - House: Bill text as passed House and Senate (HB732ER)
  • 03/25/2024 - Senate: Signed by President
  • 03/26/2024 - House: Signed by Speaker
  • 03/27/2024 - House: Impact statement from DPB (HB732ER)
  • 03/27/2024 - House: Enrolled Bill communicated to Governor on March 27, 2024
  • 03/27/2024 - Governor: Governor's Action Deadline 11:59 p.m., April 8, 2024
  • 04/04/2024 - Governor: Approved by Governor-Chapter 451 (effective 7/1/24)
  • 04/04/2024 - Governor: Acts of Assembly Chapter text (CHAP0451)